Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility

Clinical trial NCT00953862 · COMPLETED

Trial details

NCT number: NCT00953862
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2005-07-01
Primary completion: 2008-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.